CIPO Patents = 1

EPO Patents = 1

Forward Citations = 4

Loading Chart...

5 inventors (with patents filed for the assignee):

Henry Joseph Breslin (4 out of 37 patents)

Oren Gilad (4 out of 4 patents)

Gerhard Sperl (1 out of 1 patent)

4. Eric J Brown (1 out of 1 patent)

5. Laura Butler (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 10301324 - Ataxia telengiectasia and rad3-related (ATR) inhibitors and methods of their use (2019-05-28),

2. 10196405 - Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors (2019-02-05),

3. 9981989 - Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors (2018-05-29),

4. 9663535 - Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors (2017-05-30),

Company Overview

Atrin Pharmaceuticals LLC is a biopharmaceutical company dedicated to developing innovative therapies for cancer treatment. With a focus on precision medicine and targeted therapies, Atrin is committed to improving patient outcomes and quality of life. Their cutting-edge research and development efforts aim to address unmet medical needs in oncology and bring new hope to patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#7 in Ambler, PA

#2,214 in Pennsylvania

#60,671 in US

Ambler, PA, United States of America

Atrin Pharmaceuticals LLC

Forward Citations = 4

5 inventors:

Henry Joseph Breslin (4 out of 37 patents)

Oren Gilad (4 out of 4 patents)

Gerhard Sperl (1 out of 1 patent)

4. Eric J Brown (1 out of 1 patent)

5. Laura Butler (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Atrin Pharmaceuticals LLC. Retrieved from https://idiyas.com/company/atrin-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]